DP

Dr. Carlos Carrillo, MS, PhD.

SVP of Regulatory Affairs at SAB Biotherapeutics at SAB Biotherapeutics

Dr. Carlos Carrillo has extensive work experience in regulatory affairs, with a focus on ensuring compliance with FDA requirements and driving regulatory approval. Dr. Carlos is currently the SVP of Regulatory Affairs at SAB Biotherapeutics, where they create regulatory strategies for development and maintains compliance with state and federal regulations. Previously, they were the Director of Regulatory Affairs at Sagent Pharmaceuticals and Johnson Matthey Fine Chemicals, where they established relationships with worldwide partners and developed product strategies for ANDA and BLA programs. Dr. Carlos also served as the Director of Regulatory Affairs/Project Management at Wockhardt USA and Global Project Manager at Fresenius Kabi, overseeing cross-functional planning and execution. Prior to that, they worked as a Global Sr. Regulatory Associate at Hospira, Lead Scientist at Metrics/Coastal, and held various roles at Abbott Laboratories, including Operations Manager, Lead Scientist, Regulatory Associate, and Project Manager.

Dr. Carlos Carrillo, MS, PhD, has a strong educational background in the field of healthcare science and regulatory affairs. Dr. Carlos earned their Bachelor of Science (B.S.) degree in Healthcare Science from the University of Phoenix-Schaumburg IL Campus, where they studied from 2003 to 2007.

Building on this foundation, Dr. Carrillo pursued further education at Northeastern University. From 2013 to 2017, they earned a Master of Science (M.S.) degree in Drug Product Development, Patent and Intellectual Law, specializing in Regulatory Affairs for Drugs, Biologics, and Medical Devices.

Continuing their academic journey, Dr. Carrillo pursued a Ph.D. in Regulatory Law and Policy of Drug Products, Medical Devices, and Biologics at Northeastern University from 2018 to 2020. This comprehensive program focused on deepening their understanding and expertise in regulatory law and policy.

With a diverse educational background spanning healthcare science, drug product development, and regulatory affairs, Dr. Carlos Carrillo brings a wealth of knowledge and expertise to their professional pursuits.

Links

Timeline

  • SVP of Regulatory Affairs at SAB Biotherapeutics

    June, 2021 - present